APTEVO THERAPEUTICS INC - COM NEW (APVO)

CUSIP: 03835L207

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / COM NEW
Total 13F shares
632,159
Share change
+139,381
Total reported value
$5,276,105
Price per share
$8.35
Number of holders
18
Value change
+$1,169,224
Number of buys
8
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 03835L207?
CUSIP 03835L207 identifies APVO - APTEVO THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of APTEVO THERAPEUTICS INC - COM NEW (APVO) as of Q2 2020

As of 30 Jun 2020, APTEVO THERAPEUTICS INC - COM NEW (APVO) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 632,159 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, Point72 Asset Management, L.P., VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, Worth Venture Partners, LLC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., WINTON GROUP Ltd, GEODE CAPITAL MANAGEMENT, LLC, and UBS Group AG. This page lists 18 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.